You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antibodies, Blocking

Showing 26 - 50 of 7,529
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hiv Trial in Denmark, United Kingdom (Romidepsin, 3BNC117, Antiretrovirals)

Active, not recruiting
  • Hiv
  • Aalborg, Denmark
  • +6 more
Sep 3, 2021

Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

New Persistent Daily Headache Trial (CGRP antibody)

Not yet recruiting
  • New Persistent Daily Headache
  • CGRP antibody
  • (no location specified)
Aug 29, 2023

Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (Neutralizing Antibody to SPK-3006

Completed
  • Pompe Disease
  • +5 more
  • Neutralizing Antibody to SPK-3006 capsid
  • Phoenix, Arizona
  • +17 more
Jul 14, 2021

Solid Tumor Trial in Shanghai (PD-1 blocking antibody)

Recruiting
  • Solid Tumor
  • PD-1 blocking antibody
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Oct 16, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (GP+DDP, Palbociclib, Intensity-modulated radiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 2, 2021

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

"Persistence of Neutralizing Antibodies Against Yellow Fever in

Active, not recruiting
  • HIV Infections
  • Yellow Fever Vaccine
  • Yellow fever neutralizing antibodies measure
  • Antwerp, Belgium
  • +11 more
Aug 3, 2021

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Bloody Diarrhea, STEC, Unspecified, Hemolytic-Uremic Syndrome Trial in Argentina (INM004, Placebo)

Suspended
  • Bloody Diarrhea
  • +3 more
  • Bahia Blanca, Buenos Aires, Argentina
  • +6 more
Mar 28, 2022

Malaria,Falciparum Trial in Bamako (Artesunate-amodiaquine combination, Primaquine Phosphate, Artemether-lumefantrine)

Active, not recruiting
  • Malaria,Falciparum
  • Artesunate-amodiaquine combination
  • +3 more
  • Bamako, Mali
    Malaria Research and Training Centre
Jan 23, 2023

Migraine Using Enerumab and Traditional Therapy at Time of

Completed
  • Migraine Disorders
  • Fayoum, Egypt
    Marwa Kamal Ahmed Tolba
Sep 17, 2021

Neutralizing Antibody Level After COVID-19 Vaccination

Recruiting
  • Covid19
  • COVID-19 neutralizing antibody
  • Daegu, Korea, Republic of
    Kyungpook National University Hospital
Oct 18, 2021

Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])

Completed
  • Gastric Cancer
  • +2 more
  • Ramucirumab Injection
  • Ramucirumab Injection [Cyramza]
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023

Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal

Active, not recruiting
  • Localized Renal Pelvis and Ureter Urothelial Carcinoma
  • +10 more
  • Biospecimen Collection
  • +9 more
  • Birmingham, Alabama
  • +922 more
Jan 28, 2023

Quaternary Ammonium, Hypersensitivity Trial in Paris (serum punction, skin swab in elbow folds)

Not yet recruiting
  • Quaternary Ammonium
  • Hypersensitivity
  • serum punction
  • skin swab in elbow folds
  • Paris, France
    Bichat Hospital
Jul 28, 2022

Anal Melanoma, Bladder Melanoma, Cervical Melanoma Trial in United States (Cabozantinib S-malate, Nivolumab, Placebo

Recruiting
  • Anal Melanoma
  • +18 more
  • Cabozantinib S-malate
  • +5 more
  • Los Angeles, California
  • +53 more
Jan 31, 2023

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial (VG161)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Mar 22, 2022

Nonalcoholic Steatohepatitis Trial in Israel (5 mg/kg CM-101, Placebo)

Completed
  • Nonalcoholic Steatohepatitis
  • 5 mg/kg CM-101
  • Placebo
  • Be'er Sheva, Israel
  • +8 more
Apr 11, 2023

Malaria Transmission in Humans and Mosquitoes at Area of Sabou,

Active, not recruiting
  • Malaria
    • Sabou, Burkina Faso
      CMAMK
    Jul 12, 2022

    HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

    Unknown status
    • HIV
    • +2 more
    • Pegylated Interferon alpha 2b (peg-IFN-α2b)
    • 3BNC117 + 10-1074
    • Philadelphia, Pennsylvania
    • +1 more
    Jun 22, 2021

    Graves Disease, Relapse, Treatment Trial in Nanjing (Methimazole)

    Recruiting
    • Graves Disease
    • +3 more
    • Nanjing, China
      the First Affiliated Hospital of Nanjing Medical University
    Jul 21, 2022

    Schwannomatosis, Schwannomas, Pain, Chronic Trial in Boston (Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo)

    Not yet recruiting
    • Schwannomatosis
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 5, 2023

    Solid Tumor, Adult Trial in Albury (Tiragolumab, Atezolizumab)

    Not yet recruiting
    • Solid Tumor, Adult
    • Tiragolumab
    • Atezolizumab
    • Albury, New South Wales, Australia
    • +1 more
    Aug 22, 2023

    Advanced Solid Tumor Trial (NB002)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Jun 29, 2023